Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
Regular Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients, Particularly in Xeroderma Pigmentosum and Basal Cell Nevus Syndrome
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Graz, Austria, A-8036
- Medical University of Graz, Department of Dermatology
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Xeroderma pigmentosum
- Basal cell nevus syndrome
- Other patient with a history of multiple skin cancers (three or more lesions, including actinic keratosis, squamous cell carcinoma, basal cell carcinoma, and/or malignant melanoma)
Exclusion Criteria:
- Intolerance of study preparation
- Allergy against study preparation
- Non-acceptable side effects
Study Plan
How is the study designed?
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of skin cancers
Time Frame: retrospective
|
retrospective
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Patients' skin score parameters (including smoothness, color spots, wrinkles, burning, irritation, teleangiectasia, infections, warts, and skin lesions or sores)
Time Frame: retrospective
|
retrospective
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Metabolic Diseases
- Skin Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Disease
- Cysts
- Congenital Abnormalities
- Infant, Newborn, Diseases
- Genetic Diseases, Inborn
- Musculoskeletal Diseases
- Stomatognathic Diseases
- Skin Diseases, Genetic
- Bone Diseases
- Neoplastic Syndromes, Hereditary
- DNA Repair-Deficiency Disorders
- Precancerous Conditions
- Jaw Diseases
- Skin Abnormalities
- Abnormalities, Multiple
- Pigmentation Disorders
- Bone Diseases, Developmental
- Odontogenic Cysts
- Jaw Cysts
- Bone Cysts
- Carcinoma, Basal Cell
- Neoplasms, Basal Cell
- Keratosis
- Photosensitivity Disorders
- Syndrome
- Skin Neoplasms
- Basal Cell Nevus Syndrome
- Ichthyosis
- Xeroderma Pigmentosum
Other Study ID Numbers
Other Study ID Numbers
- 16-015 ex 04/05
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.